In the present study, we show that the use of the Ion Torrent PGM sequencer to sequence the coding exons of BRCA1 and BRCA2 genes substantially improves the detection rates of a wide spectrum of mutations in Polish patients with familial and/or only early onset of breast and/or ovarian cancers. This evidence concerns the gene BRCA2 and ovarian carcinoma.